FibroGen (NASDAQ: FGEN) reported Q1 EPS of $0.05, $0.15 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $2.74 million versus the consensus estimate of $35.5 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.